Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer

被引:0
|
作者
Wanchun Ye [1 ]
Xiaolei Zhang [2 ]
Zhongjie Tang [1 ]
Yufeng Hu [1 ]
Yuanliang Zheng [1 ]
Yuping Yuan [1 ]
机构
[1] The Dingli Clinical College of Wenzhou Medical University,Department of Clinical Laboratory
[2] Wenzhou Central Hospital,undefined
[3] The Second Affiliated Hospital of Shanghai University,undefined
[4] Jinan Fourth People’s Hospital,undefined
关键词
Gastric cancer; Glycometabolism; PLOD2; Immune evasion; PI3K/AKT/mTOR pathway; Prognostic model; Therapeutic resistance;
D O I
10.1186/s12876-025-03878-z
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer
    Jifeng Liu
    Lei Zhong
    Dawei Deng
    Yunshu Zhang
    Qihang Yuan
    Dong Shang
    Scientific Reports, 13 (1)
  • [22] Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
    Qian-Qian Wang
    Yuan-Chen Zhou
    Yu-Jia Zhou Ge
    Geng Qin
    Teng-Fei Yin
    Dong-Yan Zhao
    Chang Tan
    Shu-Kun Yao
    World Journal of Clinical Cases, 2022, (22) : 7686 - 7697
  • [23] The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer
    Liu, Jifeng
    Zhong, Lei
    Deng, Dawei
    Zhang, Yunshu
    Yuan, Qihang
    Shang, Dong
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [24] Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer
    Ren, Feifei
    Zhao, Qitai
    Liu, Bin
    Sun, Xiangdong
    Tang, Youcai
    Huang, Huang
    Mei, Lu
    Yu, Yong
    Mo, Hui
    Dong, Haibin
    Zheng, Pengyuan
    Mi, Yang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (03) : 2738 - 2752
  • [25] A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target
    Wen, Jia-Ying
    Fang, Ye-Ying
    Li, Dong-Ming
    Tang, Yu-Lu
    Huang, He-Qing
    Liu, Li-Min
    Zeng, Jiang-Hui
    Dang, Yi-Wu
    Pan, Yan-Fang
    Zeng, Da-Tong
    Huang, Wei-Jian
    Chen, Gang
    Li, Hui
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (09) : 673 - 689
  • [26] Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer
    Li, Qian
    Yin, Long-Kuan
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (10): : 373 - 399
  • [27] Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer
    Zhao, Wenfang
    Lin, Jiahui
    Cheng, Sha
    Li, Huan
    Shu, Yufeng
    Xu, Canxia
    PEERJ, 2023, 11
  • [28] Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
    Zeng, Tao
    Li, Bin
    Shu, Xin
    Pang, Jiahui
    Wang, Heping
    Cai, Xianghao
    Liao, Yingying
    Xiao, Xiaolong
    Chong, Yutian
    Gong, Jiao
    Li, Xinhua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] S100A6 as a Potential Serum Prognostic Biomarker and Therapeutic Target in Gastric Cancer
    Jianli Zhang
    Kejun Zhang
    Xiuli Jiang
    Jian Zhang
    Digestive Diseases and Sciences, 2014, 59 : 2136 - 2144
  • [30] S100A6 as a Potential Serum Prognostic Biomarker and Therapeutic Target in Gastric Cancer
    Zhang, Jianli
    Zhang, Kejun
    Jiang, Xiuli
    Zhang, Jian
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (09) : 2136 - 2144